» Articles » PMID: 8021781

Utah Growth Study: Growth Standards and the Prevalence of Growth Hormone Deficiency

Overview
Journal J Pediatr
Specialty Pediatrics
Date 1994 Jul 1
PMID 8021781
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Serial measurements of elementary-school children were conducted for 2 consecutive years to assess height and growth velocity and to determine the prevalence of growth hormone deficiency (GHD) in American children. Trained volunteers measured 114,881 children the first year; 79,495 growth rates were calculated after the second measurements. The height and growth velocity curves generated were very similar to the currently used charts. We examined 555 children with short stature (< 3rd percentile) and poor growth rates (< 5 cm/yr). Five percent had an endocrine disorder. The presence of GHD (peak level, < 10 ng/dl with two provocative tests) was found in 16 previously unrecognized children; 17 children from this school population were already known to have GHD. Boys outnumbered girls 2.7:1 (p = 0.006). Six girls with Turner syndrome also were identified. We conclude that (1) the growth curves generated in the 1960s and 1970s are valid for children of the 1990s; (2) most children growing < 5 cm/yr (a commonly used threshold rate) will not have an endocrine disorder; (3) many children (48% in this study) with GHD and others with Turner syndrome may currently be unrecognized and untreated; (4) GHD appears to be more common in boys; and (5) the prevalence of GHD in the United States is at least 1:3480.

Citing Articles

Utilities Associated with the Treatment of Growth Hormone Deficiency (GHD): A Time Trade-off (TTO) Study in the UK and Canada.

Kirsch S, Butler G, de Fries Jensen L, Okkels A, Yssing C, Hakan-Bloch J Patient Relat Outcome Meas. 2025; 16():9-21.

PMID: 39811679 PMC: 11731022. DOI: 10.2147/PROM.S479705.


Pituitary abnormalities in patients with pediatric growth hormone deficiency in a single tertiary center.

Jung H, Kim J, Yu J Ann Pediatr Endocrinol Metab. 2025; 29(6):365-370.

PMID: 39778405 PMC: 11725637. DOI: 10.6065/apem.2448070.035.


Genetic variations, clinical presentation and treatment outcome of isolated growth hormone deficiency type I and II: case series and review of the literature.

Li R, Yang Y, Bao X, Chen M, Yang H, Gong F Endocrine. 2024; 87(3):1171-1181.

PMID: 39562420 DOI: 10.1007/s12020-024-04102-w.


Does excessive body mass affect the rhGH therapy outcomes in GHD children?.

Maroszczuk T, Kapala J, Sitarz A, Kacka-Stanczak A, Charemska D Pediatr Endocrinol Diabetes Metab. 2024; 30(3):116-124.

PMID: 39451184 PMC: 11538918. DOI: 10.5114/pedm.2024.142590.


Sex Difference in Paediatric Growth Hormone Deficiency: Fact or Fiction?.

Henry R, Mamilly L, Chaudhari M, Pyle-Eilola A Clin Endocrinol (Oxf). 2024; 102(1):28-30.

PMID: 39380331 PMC: 11612542. DOI: 10.1111/cen.15149.